CDC6 and esophageal squamous cell carcinoma: Using comprehensive bioinformatics analysis and in vitro assays, we demonstrated that the CDC6 gene plays a key role in the progression of ESCC and serves as a novel potential biomarker and therapeutic target for ESCC.